St. Jude Medical, Inc./AGA Medical Holdings, Inc.
On October 18, 2010, St. Jude Medical, Inc. (NYSE: STJ) and AGA Medical Holdings, Inc. (Nasdaq: AGAM) announced that they have entered into an agreement whereby St. Jude Medical will acquire all of the outstanding shares of AGA Medical for $20.80 per share in cash and/or St. Jude stock, or a total consideration of $1.3 billion. The split between cash and stock consideration will be 50% of each.
The purchase price is $1.08 billion less $225 million in outstanding debt.
The merger is expected to close before the end of the year.
BofA Merrill Lynch is acting as financial advisor and Gibson, Dunn & Crutcher LLP as legal advisor to St. Jude Medical.
Piper Jaffray & Co. is acting as financial advisor and Fredrikson & Byron, P.A. as legal counsel to AGA Medical.
The purchase price is $1.08 billion less $225 million in outstanding debt.
The merger is expected to close before the end of the year.
BofA Merrill Lynch is acting as financial advisor and Gibson, Dunn & Crutcher LLP as legal advisor to St. Jude Medical.
Piper Jaffray & Co. is acting as financial advisor and Fredrikson & Byron, P.A. as legal counsel to AGA Medical.
